Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans
EGGS
1 other identifier
interventional
86
1 country
1
Brief Summary
The investigators are interested in learning more about choline, a nutrient required by the body. The body does make some choline, but it does not make enough to support health and the rest must be acquired through diet. Eggs, and especially egg yolks, are a major dietary source of choline. Choline can also be given as a dietary supplement. Ingestion of choline supplements has been linked to an increased concentration of a compound called TMAO (trimethylamine N-oxide). Elevated TMAO levels have been linked to higher heart disease risk. With this study, the investigators hope to learn whether there is a difference in the way your body responds to the ingestion of a choline supplement versus the choline found within eggs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 2, 2016
CompletedFirst Submitted
Initial submission to the registry
January 19, 2017
CompletedFirst Posted
Study publicly available on registry
February 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 3, 2020
CompletedResults Posted
Study results publicly available
May 14, 2021
CompletedNovember 4, 2025
October 1, 2025
1.6 years
January 19, 2017
April 21, 2021
October 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in Plasma Levels of Fasting Trimethylamine-N-oxide (TMAO), a Choline Metabolite
Changes in levels of non-labeled TMAO from baseline to end-of-study (day 28) as measured by established techniques by mass spectrometry.
Baseline, 28 days
Changes in Platelet Function With Increased Choline Intake
The activation and functioning of platelets within a single subject will be compared before and after increased choline intake.
Baseline, Day 28
Secondary Outcomes (8)
Changes in Levels of Fasting Trimethylamine-N-oxide (TMAO) in 24-hour Urine Collections
Baseline, Day 28
Changes in Plasma Levels of Fasting Choline
Baseline, Day 28
Changes in Plasma Levels of Fasting Carnitine.
Baseline, Day 28
Changes in Plasma Levels of Fasting Betaine.
Baseline, Day 28
Changes in Lipid Profile, Total Cholesterol
Baseline, Day 28
- +3 more secondary outcomes
Study Arms (5)
Whole Hardboiled Eggs
EXPERIMENTALSubjects will consume four (4) pre-cooked, pre-peeled whole hardboiled eggs per day for 28 days.
Choline Bitartrate Tablets
EXPERIMENTALSubjects will consume two (2) 500mg choline bitartrate tablets per day for 28 days.
Hardboiled Eggs + Choline Bitartrate Tablets
EXPERIMENTALSubjects will consume both four (4) whole, pre-cooked, pre-peeled hardboiled eggs and two (2) 500mg choline bitartrate tablets per day for 28 days.
Egg Whites + Choline Bitartrate Tablets
EXPERIMENTALSubjects will consume both the egg whites (no yolks) of four (4) pre-cooked, pre-peeled hardboiled eggs and two (2) 500mg choline bitartrate tablets per day for 28 days.
Phosphatidylcholine Capsules
EXPERIMENTALSubjects will consume six (6) 420 mg phosphatidylcholine capsules by mouth per day for 28 days.
Interventions
500mg choline bitartrate tablets
Obtained from a commercial source.
Egg whites from pre-cooked, pre-peeled hardboiled eggs. The yolks are removed and discarded.
420 mg phosphatidylcholine capsules obtained from a commercial source.
Eligibility Criteria
You may qualify if:
- Men and women age 18 years or above.
- Willing to remain on aspirin or stay off aspirin or aspirin products for 1 week prior to starting the study and throughout the study period.
- Able to provide informed consent and comply with study protocol.
- Able to be off all other supplements during the study period.
You may not qualify if:
- Significant chronic illness.
- Active infection or received antibiotics within 1 month of study enrollment.
- Use of over-the-counter probiotic within the past month
- Chronic gastrointestinal disorders, such as ulcerative colitis or Crohn's disease.
- Allergy to eggs or lactose.
- Having undergone bariatric procedures or surgeries such as gastric banding or bypass.
- Pregnancy.
- Any condition that, in the judgment of the Investigator, would place a patient at undue risk by being enrolled in the trial or cause inability to comply with the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
Related Publications (4)
Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011 Apr 7;472(7341):57-63. doi: 10.1038/nature09922.
PMID: 21475195BACKGROUNDRebouche CJ, Chenard CA. Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites. J Nutr. 1991 Apr;121(4):539-46. doi: 10.1093/jn/121.4.539.
PMID: 2007906BACKGROUNDBidulescu A, Chambless LE, Siega-Riz AM, Zeisel SH, Heiss G. Repeatability and measurement error in the assessment of choline and betaine dietary intake: the Atherosclerosis Risk in Communities (ARIC) study. Nutr J. 2009 Feb 20;8:14. doi: 10.1186/1475-2891-8-14.
PMID: 19232103BACKGROUNDWilcox J, Skye SM, Graham B, Zabell A, Li XS, Li L, Shelkay S, Fu X, Neale S, O'Laughlin C, Peterson K, Hazen SL, Tang WHW. Dietary Choline Supplements, but Not Eggs, Raise Fasting TMAO Levels in Participants with Normal Renal Function: A Randomized Clinical Trial. Am J Med. 2021 Sep;134(9):1160-1169.e3. doi: 10.1016/j.amjmed.2021.03.016. Epub 2021 Apr 17.
PMID: 33872583DERIVED
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Small sample sizes within each group created uneven distributions of some baseline characteristics; participants' dietary intake beyond the assigned interventions was not controlled during the study period; using only healthy controls makes the translatability of the results to other patient populations, like those with impaired renal function, unclear.
Results Point of Contact
- Title
- Jennifer Wilcox
- Organization
- Cleveland Clinic Foundation
Study Officials
- PRINCIPAL INVESTIGATOR
W. H. Wilson Tang, MD
The Cleveland Clinic
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff, Cardiovascular Medicine, The Cleveland Clinic; Staff, Cellular and Molecular Medicine, The Cleveland Clinic Lerner Research Institute
Study Record Dates
First Submitted
January 19, 2017
First Posted
February 1, 2017
Study Start
September 2, 2016
Primary Completion
April 10, 2018
Study Completion
September 3, 2020
Last Updated
November 4, 2025
Results First Posted
May 14, 2021
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share